Recently, Beijing NoahAI Technology Co., Ltd. ("NoahAI"), an AI-driven automation healthcare company, recently announced the completion of a Pre-A round financing worth tens of millions of RMB, led by Oriza Seed Capital with continued investment from its angel-round backer Nest.Bio Ventures.
Founded in 2023, NoahAI specializes in developing AI Agents for the healthcare industry, creating intelligent systems capable of autonomous planning and collaboration with users to address diverse needs—from medical inquiries to complex biomedical workflows. Its platform is currently accessible at www.noahai.co (free upon registration).
NoahAI's team combines deep expertise from global pharmaceutical leaders, AI innovators, and tech giants. By integrating biomedical workflows and proprietary datasets, the company has built AI Agents equipped with industry-specific tools to streamline complex tasks for healthcare professionals.
Oriza Seed Capital, a market-oriented early-stage investment platform under Oriza Holdings with assets under management exceeding RMB7 billion, focuses on technology and healthcare sectors and has built a strong reputation since 2013 for backing technology-driven startups, having invested in nearly 300 companies.
In this transaction, acted as the legal counsel to Oriza Seed Capital, Llinks leveraging its extensive experience in venture capital and private equity investments to deliver comprehensive legal services.
Llinks Engagement Team
Selena She, Partner
Colin Shi, Partner
Jerome Tang, Associate
Flora Zou, Associate
